Improve thinking with brain stimulation
- Trial ID
- NCT05919485
- Official Title
- The Effects of Specific Transcranial Direct Current Stimulation tDCS on Cognition in Mild Cognitive Impairment: A Novel Study Protocol
- Goal
- Improve thinking with brain stimulation
- Phase
- NA
- Status
- RECRUITING
- Sponsor
- Istanbul Medipol University Hospital
- Study Type
- INTERVENTIONAL
- Enrollment
- 120 participants
- Conditions
- Alzheimer Disease, Parkinson Disease
- Interventions
- tDCS
Plain-Language Summary
The goal is to see whether gentle, noninvasive electrical stimulation of the scalp can improve memory and other thinking skills in people with mild cognitive impairment related to Parkinson's or early Alzheimer's. The approach uses transcranial direct current stimulation, a very low, painless current applied to targeted brain regions to boost neuronal activity involved in memory and attention, and it is given alongside participants' regular medications rather than replacing levodopa or other drugs. They are enrolling 120 literate adults aged 45 to 80, balanced by sex, who have Parkinson's with mild cognitive impairment or amnestic MCI, are on stable medications for at least one month, and who do not have dementia, major medical or other neurologic/psychiatric conditions, or any contraindication to tDCS or fMRI.
Locations
- Alanya Alaaddin Keykubat Üniversitesi, Antalya, Alanya, Turkey (Türkiye)
Frequently Asked Questions
- What is this trial testing?
- This trial is studying tDCS. The goal is to see whether gentle, noninvasive electrical stimulation of the scalp can improve memory and other thinking skills in people with mild cognitive impairment related to Parkinson's or early Alzheimer's. The approach uses transcranial direct current stimulation, a very low, painless current applied to targeted brain regions to boost neuronal activity involved in memory and attention, and it is given alongside participants' regular medications rather than replacing levodopa or other drugs. They are enrolling 120 literate adults aged 45 to 80, balanced by sex, who have Parkinson's with mild cognitive impairment or amnestic MCI, are on stable medications for at least one month, and who do not have dementia, major medical or other neurologic/psychiatric conditions, or any contraindication to tDCS or fMRI.
- Who can participate?
- Participants must be between 45 Years and 80 Years.
- Where is this trial located?
- This trial is recruiting at 1 location.
- Does it cost anything to join?
- No. There is no cost to participate. Study-related care and treatment are provided at no charge.
- How long does the trial last?
- This trial is estimated to last approximately 5 months.